| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.048 | 0.8 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |